We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
11876
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$132K ﹤0.01%
8,752
+4,504
+106% +$94.2K
BW icon
11877
CALL
Babcock & Wilcox
BW
$1.37B
$131K ﹤0.01%
16,100
-14,700
-48% -$115K
CSBR icon
11878
Champions Oncology
CSBR
$69.3M
$131K ﹤0.01%
+16,079
New +$129K
DRIO icon
11879
CALL
DarioHealth
DRIO
$74.8M
$131K ﹤0.01%
1,125
-1,640
-59% -$271K
ESRT icon
11880
CALL
Empire State Realty Trust
ESRT
$802M
$131K ﹤0.01%
13,300
-5,500
-29% -$51.8K
VNDA icon
11881
PUT
Vanda Pharmaceuticals
VNDA
$298M
$131K ﹤0.01%
11,600
-7,500
-39% -$98.6K
CSLMR
11882
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$131K ﹤0.01%
+874,600
New +$142K
TCON
11883
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$131K ﹤0.01%
2,487
+1,398
+128% +$70.3K
HBP
11884
CALL
DELISTED
Huttig Building Products, Inc.
HBP
$131K ﹤0.01%
12,300
-4,300
-26% -$41.1K
ATIP
11885
PUT
DELISTED
ATI Physical Therapy, Inc.
ATIP
$131K ﹤0.01%
1,390
-1,126
-45% -$143K
API
11886
PUT
Agora
API
$395M
$130K ﹤0.01%
13,100
-12,100
-48% -$136K
GNPX icon
11887
CALL
Genprex
GNPX
$2.26M
$130K ﹤0.01%
1
NINE
11888
PUT
DELISTED
Nine Energy Service
NINE
$130K ﹤0.01%
34,800
+24,300
+231% +$45.7K
TROO icon
11889
CALL
TROOPS Inc
TROO
$239M
$130K ﹤0.01%
30,400
-18,200
-37% -$79.4K
VEON icon
11890
VEON
VEON
$3.92B
$130K ﹤0.01%
7,598
-146,291
-95% -$3.98M
ARQ icon
11891
PUT
Arq
ARQ
$97.4M
$130K ﹤0.01%
20,900
+2,800
+15% +$17.8K
BCSAW
11892
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$130K ﹤0.01%
+300,000
New +$164K
KLR
11893
PUT
DELISTED
Kaleyra, Inc.
KLR
$130K ﹤0.01%
6,200
-3,743
-38% -$104K
PMGMU
11894
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$130K ﹤0.01%
13,154
-1
-0% -$10
PGRWU
11895
DELISTED
Progress Acquisition Corp. Units
PGRWU
$130K ﹤0.01%
13,133
HYRE
11896
CALL
DELISTED
HyreCar Inc. Common Stock
HYRE
$130K ﹤0.01%
54,800
-51,400
-48% -$159K
AMTX icon
11897
Aemetis
AMTX
$123M
$129K ﹤0.01%
10,156
-59,147
-85% -$652K
LFCR icon
11898
CALL
Lifecore Biomedical
LFCR
$183M
$129K ﹤0.01%
+11,100
New +$124K
NABL icon
11899
PUT
N-able
NABL
$593M
$129K ﹤0.01%
14,200
+1,250
+10% +$13.2K
JWSM.WS
11900
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$129K ﹤0.01%
261,960

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.